Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-α, oxidative stress, and insulin resistance in type 2 diabetic subjects: Randomized, double-blind, placebo-controlled study

Molecular Nutrition and Food Research

Volumn 56, Issue 8, 2012, Pages 1333-1341

  Jain, Sushil K ^a   Kahlon, Gunjan ^a   Morehead, Lester ^a   Dhawan, Richa ^a   Lieblong, Benjamin ^a   Stapleton, Tommie ^a   Caldito, Gloria ^a   Hoeldtke, Robert ^a   Levine, Steven N ^a   Bass, Pat Farrington ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Chromium; Diabetes; Insulin resistance; l cysteine; Oxidative stress

Indexed keywords

CHROMIUM DINICOCYSTEINATE; CYSTEINE; DRUG DERIVATIVE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; ORGANOMETALLIC COMPOUND; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL;

ADULT; CYSTEINE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865126750     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100719     Document Type: Article

References (38)

1. Vincent, J.-B., Recent advances in the nutritional biochemistry of trivalent chromium. Proc. Nutr. Soc. 2004, 63, 41-47.
2. Cefalu, W.-T., Hu, F.-B., Role of chromium in human health and in diabetes. Diab. Care 2004, 27, 2741-2751.
3. Balk, E. M., Tatsioni, A., Lichtenstein, A. H., Lau, J. et al., Effect of chromium supplementation on glucose metabolism and lipids. Diabetes Care 2007, 30, 2154-2163.
4. Hummel, M., Standl, E., Schnell, O., Chromium in metabolic and cardiovascular disease. Horm. Metabolic Disease 2007, 39, 743-751.
5. Anderson, R.-A., Cheng, N., Bryden, N.-A., Polansky, M.-M. et al., Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997, 46, 1786-1791.
6. Rajpathak, S., Rimm, E.-B., Li, T., Morris, J.-S. et al., Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care 2004, 27, 2211-2216.
7. Cefalu, W. T., Wang, Z. Q., Zhang, X. H., Baldor, L. C. et al., Oral chromium picolinate improves carbohydrate and lipid metabolism and enhance skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J. Nutr. 2002, 132, 1107-1114.
8. Singh, U., Devraj, S., Jialal, I., Vitamin E, oxidative stress and inflammation. Ann. Rev. Nutr. 2005, 25, 151-174.
9. Rains, J. L., Jain, S. K., Oxidative stress, insulin signaling and diabetes. Free Rad. Biol. Med. 2011, 50, 567-575.
10. Pennathur, S., Heinecke, J. W., Mechanisms for oxidative stress in diabetic cardiovascular disease. Antiox. Redox. Signal 2007, 9, 955-969.
11. Evans, J. L., Maddux, B. A., Goldfine, I. D., The molecular basis for oxidative stress-induced insulin resistance. Antiox. Redox. Signal 2005, 7, 1040-1052.
12. Yaturu, S., Daberry, B., Rains, J., Jain, S.-K., Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes. Cytokine 2006, 34, 219-223.
13. Sekhar, R. V., McKay, S. V., Patel, S. G., Guthikonda, A. P. et al., Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care 2011, 34, 162-167.
14. Darmaun, D., Smith, S. D., Sweeten, S., Hartman, B. K. et al., Poorly controlled type 1 diabetes is associated with altered glutathione homeostasis in adolescents: apparent resistance to N-acetylcysteine supplementation. Pediatr. Diabetes 2008, 9, 577-582.
15. Dröge, W., Oxidative stress and ageing: is ageing a cysteine deficiency syndrome? Philos. Trans. R Soc. Lond. B Biol. Sci. 2005, 360, 2355-2372.
16. Blouet, C., Mariotti, F., Mikogami, T., Tome, D. et al., Meal cysteine improves postprandial glucose control in rats fed a high-sucrose meal. J. Nutr. Biochem. 2007, 18, 519-524.
17. Blouet, C. B., Mariotti, F., Azzout-Marniche, D., Mathe, V. et al., Dietary cysteine alleviates sucrose-induced oxidative stress and insulin resistance. Free Radic. Biol. Med. 2007, 42, 1089-1097.
18. Song, D., Hutchings, S., Pang, C. C. Y., Chronic N-acetylcysteine prevents fructose-induced insulin resistance and hypertension in rats. Eu. J. Pharmacol. 2005, 508, 205-210.
19. Hsu, C. C., Yen, H. F., Yin, M. C., Tsai, C. M. et al., Five cysteine-containing compounds delay diabetic deterioration in Balb/cA mice. J. Nutr. 2004, 134, 3245-3249.
20. Jain, S. K., Velusamy, T., Croad, J. L., Rains, J. L. et al., L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, oxidative stress and inhibits NFkB activation in the livers of Zucker diabetic rats. Free Radic. Biol. Med. 2009, 46, 1633-1638.
21. Iyer, S. S., Accardi, C. J., Ziegler, T. R., Blanco, R. A. et al., Cysteine redox potential determines pro-inflammatory IL-1beta levels. PLoS One 2009, 4, e5017. DOI:10.1371/journal.pone.0005017
22. Jain, S. K., Croad, J. L., Velusamy, T., Rains, J. L. et al., Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkB, Akt, and Glut-2 in livers of zucker diabetic fatty rats. Mol. Nutr. Food Res. 2010, 54, 1371-80.
23. Jain, S.-K., Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J. Biol. Chem. 1989, 264, 21340-21345.
24. Jain, S.-K., McVie, R., Duett, J., Herbst, J.-J., Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989, 1539-1543.
25. Otani, H., Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antiox. Redox. Signal 2011, 15, 1911-1926.
26. Jain, S.-K., Kannan, K., Chromium chloride inhibits oxidative stress and TNF-α secretion caused by exposure to high glucose in cultured monocytes. Biochem. Biophys. Res. Commun. 2001, 289, 687-691.
27. Jones, D. P., Radical-free biology of oxidative stress. Am. J. Cell Physiol. 2008, 249, C849-C868.
28. Jain, S.-K., Rains, J., Croad, J., Effect of chromium niacinate and chromium picolinate supplementation on fasting blood glucose, HbA1, TNF-α, IL-6, CRP, cholesterol, triglycerides and lipid peroxidation levels in streptozotocine treated diabetic rats. Free Radical Biol. Med. 2007, 43, 1124-1131.
29. Merino-Ibarra, E., Artieda, M., Cenarro, A., Goicoechea, J. et al., Ultrasonography for the evaluation of visceral fat and the metabolic syndrome. Metabolism 2005, 54, 1230-1235.
30. Hayashi, T., Boyko, E. J., McNeely, M. J., Leonetti, D. L. et al., Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes 2008, 57, 1269-1275.
31. Nyholm, B., Nielsen, M. F., Kristensen, K., Nielsen, S. et al., Evidence of increased visceral obesity and reduced physical fitness in healthy insulin-resistant first-degree relatives of type 2 diabetic patients. Eur. J. Endocrinol. 2004, 150, 207-214.
32. Lorenzo, M., Fernandez-Veledo, S., Vila-Bedmar, R., Garcia-Guerra, L. et al., Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. J. Anim. Sci. 2008, 86, E94-E104.
33. Feinstein, R., Kanety, H., Papa, M. Z., Lunenfeld, B. et al., Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem. 1993, 268, 26055-26058.
34. Nieto-Vazquez, I., Fernandez-Veledo, S., Kramer, D. K., Vila-Bedmar, R. et al., Insulin resistance associated to obesity: the link TNF-alpha. Arch. Physiol. Biochem. 2008, 114, 183-194.
35. Greenfield, J. R., Campbell, L. V., Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Curr. Diabetes Rev. 2006, 2, 195-211.
36. Hotamisligil, G. S., Spiegelman, B. M., Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994, 43, 1271-1278.
37. Hartge, M. M., Unger, T., Kintscher, U., The endothelium and vascular inflammation in diabetes. Diab. Vasc. Dis. Res. 2007, 4, 84-88.
38. Hsueh, W. A., Quinones, M. J., Role of endothelial dysfunction in insulin resistance. Am. J. Cardiol. 2003, 92, 10J-17J.